The Convergence of Digital Health and Life Sciences

Despite the challenges of interoperability, regulatory compliance, technology adoption, and data privacy, the benefits of digital health are undeniable. Collaboration between policymakers, clinicians, IT developers, and patients, can help overcome these obstacles. The post The Convergence of Digital Health and Life Sciences appeared first on MedCity News.

Read More

Links

Tyler Cowen on the price of Ozempic.Problems with the OMB’s social welfare function. Link between alcohol and cancer. Disparities in the rural-urban life expectancy.Why will Part D plans “…move drugs that are selected for [MFP] negotiation into a higher cost-sharing tier”?

Read More

Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline

Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed programs that hit a target unaddressed by any currently available CF therapies. The post Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline appeared first on…

Read More

Trust and AI Adoption in Medicine

The challenge isn’t whether AI can be used (it already is). It’s whether it can be trusted. And trust in medicine is not something healthcare professionals can afford to get wrong.  The post Trust and AI Adoption in Medicine appeared first on MedCity News.

Read More